Retrospective Matched-Cohort Analysis of Acute Pancreatitis Induced by 5-Aminosalicylic Acid-Derived Drugs
This study aimed to compare the clinical course of 5-aminosalicylic acid-derived, drug-induced acute pancreatitis (5-ASA-DIAP) to acute pancreatitis (AP) caused by other etiologies.A cohort of patients with 5-ASA-DIAP was established through literature search. As a control AP (CAP) group, a cohort w...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2019
|
| Sorozat: | PANCREAS
48 No. 4 |
| doi: | 10.1097/MPA.0000000000001297 |
| mtmt: | 30623978 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/16410 |
| LEADER | 02309nab a2200277 i 4500 | ||
|---|---|---|---|
| 001 | publ16410 | ||
| 005 | 20190821153351.0 | ||
| 008 | 190821s2019 hu o 0|| zxx d | ||
| 022 | |a 0885-3177 | ||
| 024 | 7 | |a 10.1097/MPA.0000000000001297 |2 doi | |
| 024 | 7 | |a 30623978 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a zxx | ||
| 100 | 1 | |a Meczker Ágnes | |
| 245 | 1 | 0 | |a Retrospective Matched-Cohort Analysis of Acute Pancreatitis Induced by 5-Aminosalicylic Acid-Derived Drugs |h [elektronikus dokumentum] / |c Meczker Ágnes |
| 260 | |c 2019 | ||
| 300 | |a 488-495 | ||
| 490 | 0 | |a PANCREAS |v 48 No. 4 | |
| 520 | 3 | |a This study aimed to compare the clinical course of 5-aminosalicylic acid-derived, drug-induced acute pancreatitis (5-ASA-DIAP) to acute pancreatitis (AP) caused by other etiologies.A cohort of patients with 5-ASA-DIAP was established through literature search. As a control AP (CAP) group, a cohort was generated from a registry. Data on the diagnostic procedure, symptoms, enzyme elevation, imaging, severity, and recovery parameters were collected. Causality was assessed using the Naranjo algorithm.Twenty-nine articles were included, which describe 36 patients with fifty-one 5-ASA-DIAP episodes (60.78% female, 39.22% male). There were 88.2% mild, 3.92% moderate, and 7.84% severe cases of AP in the 5-ASA-DIAP group, and 70.6%, 25.5%, and 3.92% such cases in the CAP population, respectively. Symptoms improved significantly faster (mean ± SE, 2.5 ± 0.34 vs 3.74 ± 0.42 days; P = 0.018); however, pancreatic enzyme levels normalized significantly more slowly (6.27 ± 1.53 vs 3.63 ± 0.61 days, P = 0.008) in the 5-ASA-DIAP cohort compared with the CAP group. This study confirms that there are no diagnostic differences between 5-ASA-DIAP and AP of other etiologies.Fewer moderate but more severe cases were found in the 5-ASA-DIAP group; therefore, 5-ASA-DIAP must be taken as seriously as AP of other etiologies. | |
| 700 | 0 | 1 | |a Mikó Alexandra |e aut |
| 700 | 0 | 1 | |a Gede Noémi |e aut |
| 700 | 0 | 1 | |a Szentesi Andrea Ildikó |e aut |
| 700 | 0 | 1 | |a Párniczky Andrea |e aut |
| 700 | 0 | 1 | |a Gódi Szilárd |e aut |
| 700 | 0 | 1 | |a Hegyi Péter |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/16410/1/30623978_Meczker_2019_Retrospective_Matched_Cohort_Analysis_of_Acute.4.pdf |z Dokumentum-elérés |